On February 4, 2020, the Wuhan Institute of Virology announced it applied for a patent for Gilead’s Remdesivir, which shows promise in treating COVID-19. The China National Intellectual Property Administration (CNIPA) has apparently published the application with publication number CN111265532A entitled “Use of substituted aminopropionate compounds in the treatment of 2019-nCoV infection.” However, the applicant is the Academy of Military Medical Sciences instead of the Wuhan Institute of Virology (the Academy’s research partner). As first reported by 韩百科君, CNIPA is …
Category: Patents
China’s State Administration for Market Regulation Releases National Plan to Combat Intellectual Property Infringement
On June 5, 2020 China’s State Administration for Market Regulation (SAMR), which regulates market competition, monopolies, intellectual property, and drug safety, released a national plan to combat intellectual property infringement. The plan is officially entitled “Key Points of the National Work to Crack Down on Intellectual Property Infringement and the Production and Sale of Counterfeit and Inferior Commodities in 2020.” The plan lists 35 points in 6 areas covering trademark, patent, copyright, and trade secret protection and makes special emphasis …
China’s Patent Application Filings Continue Upsurge Surpassing 2019 Year-on-Year
The China National Intellectual Property Administration (CNIPA) just released statistics for January through May 2020 showing cumulative patent application filings year-to-date now exceed 2019’s filings at this time last year. Cumulatively, applicants filed 549,536 invention patent applications this year versus 542,106 last year. For the month, May 2020 invention patent filings were up almost 12% versus May 2019 with 114,854 invention patent application filings in May 2020 versus 102,835 invention patent applications filed in May 2019.
The China National Intellectual Property Administration Aims to Speed Up Patent Prosecution
The China National Intellectual Property Administration (CNIPA) released its annual budget on June 11, 2020. Besides a significant amount of financial data, the budget shows performance goals and indicators. The current examination time to final disposition for an invention patent application is 22 months with a 2022 goal of 16.5 months. Patent invalidations are relatively fast at 6 months with a goal of maintaining this level.